BR9814866A - Uso de oligÈmeros de ácido poliamida nucléicopara produzir uma resposta biológica - Google Patents
Uso de oligÈmeros de ácido poliamida nucléicopara produzir uma resposta biológicaInfo
- Publication number
- BR9814866A BR9814866A BR9814866-4A BR9814866A BR9814866A BR 9814866 A BR9814866 A BR 9814866A BR 9814866 A BR9814866 A BR 9814866A BR 9814866 A BR9814866 A BR 9814866A
- Authority
- BR
- Brazil
- Prior art keywords
- produce
- biological response
- nucleic acid
- provides methods
- acid oligomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C07K14/003—Peptide-nucleic acids (PNAs)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
- C12N2310/3181—Peptide nucleic acid, PNA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyamides (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Patente de Invenção: "USO DE OLIGÈMEROS DE áCIDOPOLIAMIDA NUCLéICO PARA PRODUZIR UMA RESPOSTABIOLóGICA". A invenção provê métodos de tratamento de célulasvivas com oligómeros de PNA de modo que os oligómerosatravessam uma barreira biológica e produzem uma respostabiológica. A invenção provê métodos para a triagem de oligómerosde PNA potenciais quanto a capacidade de produzir uma respostabiológica específica de seq³ência?. A invenção também provêmétodos de identificação da função de polipeptídeos e dadeterminação da taxa de mudança relativa de polipeptídeosfuncionais.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/953,269 US6472209B1 (en) | 1997-10-17 | 1997-10-17 | Using polyamide nucleic acid oligomers to engender a biological response |
US09/016,685 US6743627B1 (en) | 1997-10-17 | 1998-01-30 | Using polyamide nucleic acid oligomers to engender a biological response |
US16851998A | 1998-10-08 | 1998-10-08 | |
US09/168,791 US6723560B2 (en) | 1998-10-08 | 1998-10-08 | Using polyamide nucleic acid oligomers to engender a biological response |
US09/168,714 US6989270B1 (en) | 1997-10-17 | 1998-10-08 | Using polyamide nucleic acid oligomers to engender a biological response |
PCT/US1998/021888 WO1999020643A1 (en) | 1997-10-17 | 1998-10-16 | Using polyamide nucleic acid oligomers to engender a biological response |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9814866A true BR9814866A (pt) | 2001-11-20 |
Family
ID=27533701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9814866-4A BR9814866A (pt) | 1997-10-17 | 1998-10-16 | Uso de oligÈmeros de ácido poliamida nucléicopara produzir uma resposta biológica |
Country Status (12)
Country | Link |
---|---|
US (1) | US6989270B1 (pt) |
EP (1) | EP1042349B1 (pt) |
JP (1) | JP2003523307A (pt) |
AT (1) | ATE405575T1 (pt) |
AU (1) | AU741246B2 (pt) |
BR (1) | BR9814866A (pt) |
CA (1) | CA2306731A1 (pt) |
DE (1) | DE69839921D1 (pt) |
DK (1) | DK1042349T3 (pt) |
ES (1) | ES2312192T3 (pt) |
IL (1) | IL135705A0 (pt) |
WO (1) | WO1999020643A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6472209B1 (en) | 1997-10-17 | 2002-10-29 | Mayo Foundation For Medical Education And Research | Using polyamide nucleic acid oligomers to engender a biological response |
US6989270B1 (en) | 1997-10-17 | 2006-01-24 | Mayo Foundation For Medical Education And Research | Using polyamide nucleic acid oligomers to engender a biological response |
US6723560B2 (en) | 1998-10-08 | 2004-04-20 | Mayo Foundation For Medical Education And Research | Using polyamide nucleic acid oligomers to engender a biological response |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE171185T1 (de) | 1985-03-15 | 1998-10-15 | Antivirals Inc | Immunotestmittel für polynukleotid und verfahren |
US5217866A (en) | 1985-03-15 | 1993-06-08 | Anti-Gene Development Group | Polynucleotide assay reagent and method |
US5470974A (en) | 1985-03-15 | 1995-11-28 | Neu-Gene Development Group | Uncharged polynucleotide-binding polymers |
US5783682A (en) | 1990-07-27 | 1998-07-21 | Isis Pharmaceuticals, Inc. | Oligonucleotide mimics having nitrogen-containing linkages |
DK51092D0 (da) | 1991-05-24 | 1992-04-15 | Ole Buchardt | Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf |
US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
US5719262A (en) | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
US5641625A (en) | 1992-05-22 | 1997-06-24 | Isis Pharmaceuticals, Inc. | Cleaving double-stranded DNA with peptide nucleic acids |
WO1995004749A1 (en) | 1993-08-05 | 1995-02-16 | Isis Pharmaceuticals, Inc. | Oligomers for modulating metabolic function |
WO1995004748A1 (en) | 1993-08-09 | 1995-02-16 | Isis Pharmaceuticals, Inc. | Oligomers for modulating viral processes |
US6156501A (en) | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
GB2284209A (en) | 1993-11-25 | 1995-05-31 | Ole Buchardt | Nucleic acid analogue-induced transcription of RNA from a double-stranded DNA template |
US5703067A (en) * | 1995-05-08 | 1997-12-30 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
WO1996035705A1 (en) | 1995-05-10 | 1996-11-14 | Isis Pharmaceuticals, Inc. | Inhibition of transcription factor-mediated transcriptional activation by oligomer strand invasion |
US6015710A (en) | 1996-04-09 | 2000-01-18 | The University Of Texas System | Modulation of mammalian telomerase by peptide nucleic acids |
GB9608803D0 (en) | 1996-04-27 | 1996-07-03 | Univ Newcastle | Mitochondrial dna defects |
IL133087A0 (en) | 1997-05-28 | 2001-03-19 | Nielsen Peter E | Conjugated peptide nucleic acids having enhanced cellular uptake |
US6025140A (en) | 1997-07-24 | 2000-02-15 | Perseptive Biosystems, Inc. | Membrane-permeable constructs for transport across a lipid membrane |
US6300318B1 (en) | 1997-09-16 | 2001-10-09 | Peter E. Nielsen | Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor |
WO1999013719A1 (en) | 1997-09-18 | 1999-03-25 | Gene Therapy Systems, Inc. | Chemical modification of dna using peptide nucleic acid conjugates |
US6472209B1 (en) * | 1997-10-17 | 2002-10-29 | Mayo Foundation For Medical Education And Research | Using polyamide nucleic acid oligomers to engender a biological response |
US6989270B1 (en) | 1997-10-17 | 2006-01-24 | Mayo Foundation For Medical Education And Research | Using polyamide nucleic acid oligomers to engender a biological response |
-
1998
- 1998-10-08 US US09/168,714 patent/US6989270B1/en not_active Expired - Fee Related
- 1998-10-16 AT AT98953610T patent/ATE405575T1/de not_active IP Right Cessation
- 1998-10-16 WO PCT/US1998/021888 patent/WO1999020643A1/en active IP Right Grant
- 1998-10-16 ES ES98953610T patent/ES2312192T3/es not_active Expired - Lifetime
- 1998-10-16 JP JP2000516984A patent/JP2003523307A/ja active Pending
- 1998-10-16 DK DK98953610T patent/DK1042349T3/da active
- 1998-10-16 EP EP98953610A patent/EP1042349B1/en not_active Expired - Lifetime
- 1998-10-16 BR BR9814866-4A patent/BR9814866A/pt not_active IP Right Cessation
- 1998-10-16 IL IL13570598A patent/IL135705A0/xx unknown
- 1998-10-16 CA CA002306731A patent/CA2306731A1/en not_active Abandoned
- 1998-10-16 AU AU10940/99A patent/AU741246B2/en not_active Ceased
- 1998-10-16 DE DE69839921T patent/DE69839921D1/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK1042349T3 (da) | 2008-11-10 |
AU741246B2 (en) | 2001-11-29 |
ATE405575T1 (de) | 2008-09-15 |
EP1042349B1 (en) | 2008-08-20 |
ES2312192T3 (es) | 2009-02-16 |
EP1042349A4 (en) | 2004-07-28 |
DE69839921D1 (de) | 2008-10-02 |
JP2003523307A (ja) | 2003-08-05 |
CA2306731A1 (en) | 1999-04-29 |
AU1094099A (en) | 1999-05-10 |
WO1999020643A9 (en) | 1999-08-05 |
WO1999020643A1 (en) | 1999-04-29 |
US6989270B1 (en) | 2006-01-24 |
IL135705A0 (en) | 2001-05-20 |
EP1042349A1 (en) | 2000-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE364704T1 (de) | Mutanten von op-1 | |
DE69638248D1 (de) | Nachweis von DNS-Sequenz Variationen | |
DE19781288T1 (de) | Opake Reaktionsmatrix zur Analyse von Vollblut | |
ATE397251T1 (de) | Verfahren für das entwerfen von kleinen erythropoietin mimetika | |
BR9814386B1 (pt) | aparelhos e métodos para determinar a concentração de um componente medicamente significante de um fluido biológico. | |
ID23953A (id) | Asam 5-alkil-2-arilaminofenilasetat dan turunannya | |
BR9505199A (pt) | Processo de detecção e/ou de medida de variações de uma grandeza fisica com o auxilio de um captador distribuido ou combinado | |
ES2133813T3 (es) | Cadenas de lamininas: diagnostico y uso terapeutico. | |
DE69823214D1 (de) | Kit zur Längenbestimmung von Kathetern vor ihrer Einführung | |
PT653439E (pt) | Oligonucleotidos e sua aplicacao | |
ATE179215T1 (de) | 4,7-dichlorfluoreszein-farbstoffe als molekulare sonden | |
DE3674642D1 (de) | Zur modifizierung von bitumen verwendbare polymerzusammensetzungen und so modifizierte bitumenmassen. | |
DE69800720D1 (de) | Reagenz zur Färbung von Blutzellen | |
DE69731646D1 (de) | Verabreichung von nukleinsäurepartikeln | |
ES2141249T3 (es) | Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores. | |
BR9814866A (pt) | Uso de oligÈmeros de ácido poliamida nucléicopara produzir uma resposta biológica | |
BR0014626A (pt) | Análise de leptina | |
ATE169314T1 (de) | Arylthioethereinheiten enthaltende naphthalendicarboxsäure polymere mit verminderterfluoreszenz | |
ATE205600T1 (de) | Leukozytadhaesiontest | |
ATE390440T1 (de) | Neuroaktive peptide | |
ES2187939T3 (es) | Moleculas aisladas de acido nucleico codificantes de miembros de la familia ssx y utilizaciones de las mismas. | |
DE59800998D1 (de) | Verwendung von polyamiden als deformationsstabilisatoren für polymere | |
DE69835974D1 (de) | Nachweis und Quantifizierung von einen oder mehreren Nukleotidsequenzen durch Benutzung von räumlich lokalisierte Target Replikation | |
DE69019632D1 (de) | Koazervate von Builderpolymeren und ihre Verwendung. | |
ATE389727T1 (de) | Modulatoren der expression von morphogenen und deren identifizierungsverfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1917 DE 02/10/2007. |